Eledon Pharmaceuticals ELDN Stock
Eledon Pharmaceuticals Price Chart
Eledon Pharmaceuticals ELDN Financial and Trading Overview
| Eledon Pharmaceuticals stock price | 3.05 USD |
| Previous Close | 1.71 USD |
| Open | 1.67 USD |
| Bid | 0 USD x 2900 |
| Ask | 0 USD x 1100 |
| Day's Range | 1.6 - 1.75 USD |
| 52 Week Range | 1.57 - 3.93 USD |
| Volume | 84.51K USD |
| Avg. Volume | 192.38K USD |
| Market Cap | 37.14M USD |
| Beta (5Y Monthly) | 2.049295 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.4 USD |
ELDN Valuation Measures
| Enterprise Value | -8680523 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.2222222 |
| PEG Ratio (5 yr expected) | 0.02 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.30392337 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Eledon Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 2.049295 |
| 52-Week Change | -39.78% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.93 USD |
| 52 Week Low | 1.57 USD |
| 50-Day Moving Average | 2.21 USD |
| 200-Day Moving Average | 2.56 USD |
ELDN Share Statistics
| Avg. Volume (3 month) | 192.38K USD |
| Avg. Daily Volume (10-Days) | 129.66K USD |
| Shares Outstanding | 22.51M |
| Float | 16.98M |
| Short Ratio | 0.11 |
| % Held by Insiders | 10.05% |
| % Held by Institutions | 48.65% |
| Shares Short | 50.5K |
| Short % of Float | 0.25% |
| Short % of Shares Outstanding | 0.22% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:18 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -21.047% |
| Return on Equity (ttm) | -76.90% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -88874000 USD |
| Diluted EPS (ttm) | -5.81 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 46.49M USD |
| Total Cash Per Share (mrq) | 2.07 USD |
| Total Debt (mrq) | 668K USD |
| Total Debt/Equity (mrq) | 0.89 USD |
| Current Ratio (mrq) | 8.927 |
| Book Value Per Share (mrq) | 5.429 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -30192000 USD |
| Levered Free Cash Flow (ttm) | -15231375 USD |
Profile of Eledon Pharmaceuticals
| Country | United States |
| State | CA |
| City | Irvine |
| Address | 19900 MacArthur Boulevard |
| ZIP | 92612 |
| Phone | 949 238 8090 |
| Website | https://eledon.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 17 |
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Q&A For Eledon Pharmaceuticals Stock
What is a current ELDN stock price?
Eledon Pharmaceuticals ELDN stock price today per share is 3.05 USD.
How to purchase Eledon Pharmaceuticals stock?
You can buy ELDN shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Eledon Pharmaceuticals?
The stock symbol or ticker of Eledon Pharmaceuticals is ELDN.
Which industry does the Eledon Pharmaceuticals company belong to?
The Eledon Pharmaceuticals industry is Biotechnology.
How many shares does Eledon Pharmaceuticals have in circulation?
The max supply of Eledon Pharmaceuticals shares is 59.88M.
What is Eledon Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Eledon Pharmaceuticals PE Ratio is now.
What was Eledon Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Eledon Pharmaceuticals EPS is -0.04 USD over the trailing 12 months.
Which sector does the Eledon Pharmaceuticals company belong to?
The Eledon Pharmaceuticals sector is Healthcare.
Eledon Pharmaceuticals ELDN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 18737.21 USD — |
-1
|
7.88B USD — | 18599.69 USD — | 18841.52 USD — | — - | 7.88B USD — |
| Nasdaq Health Care IXHC | 932.02 USD — |
-0.03
|
— — | 920.46 USD — | 933.54 USD — | — - | — — |
- {{ link.label }} {{link}}